Peter D. Turnbaugh

Peter D. Turnbaugh
Name	Peter D. Turnbaugh
Fields	Microbiology; Microbiome research; Pharmacology
Workplaces	University of California, San Francisco; Harvard University; Broad Institute; University of California, Berkeley
Alma mater	University of California, Berkeley; Harvard Medical School
Known for	Research on gut microbiome and drug metabolism

Peter D. Turnbaugh is an American scientist known for research at the intersection of microbiology, pharmacology, and human health. He leads investigations into the gut microbiome's role in modulating therapeutics and diet-related phenotypes, collaborating with investigators across academic, clinical, and biotechnology institutions. His work bridges laboratory studies with translational efforts involving patient cohorts, regulatory agencies, and industry partners.

Early life and education

Turnbaugh completed undergraduate and graduate training at institutions linked to major biomedical centers. He attended University of California, Berkeley for undergraduate studies and pursued doctoral training that connected to research groups at Harvard University and the Broad Institute. He undertook postdoctoral research affiliated with Harvard Medical School laboratories and clinical groups at the University of California, San Francisco, developing expertise that combined methods from Stanford University-style microbial ecology, Massachusetts Institute of Technology-inspired systems biology, and translational frameworks used at the National Institutes of Health.

Research and career

Turnbaugh established a multidisciplinary laboratory focused on the interactions between host, diet, microbes, and xenobiotics, engaging with centers such as the University of California, San Francisco, the University of California, Berkeley, and consortia including the Human Microbiome Project and research networks connected to the National Institutes of Health. His career includes faculty appointments and collaborations with investigators at the Broad Institute, the Chan Zuckerberg Biohub, and clinical departments at tertiary centers like UCSF Medical Center and affiliated hospitals. He employs tools developed at places such as the Broad Institute and Howard Hughes Medical Institute-supported laboratories: gnotobiotic animal models, shotgun metagenomics, metabolomics platforms pioneered by groups at the Scripps Research Institute and University of Chicago, and chemical biology approaches informed by work at the Salk Institute.

Turnbaugh's lab collaborates with clinical investigators in gastroenterology, oncology, and infectious disease at institutions like Massachusetts General Hospital, Brigham and Women's Hospital, and the Fred Hutchinson Cancer Research Center to translate microbiome findings into clinical contexts. He interacts with regulatory and funding bodies including the National Institutes of Health, the National Science Foundation, and philanthropic funders associated with the Gordon and Betty Moore Foundation and the Bill & Melinda Gates Foundation.

Major contributions and discoveries

Turnbaugh has contributed to understanding how gut microbial communities influence host metabolism, drug efficacy, and adverse drug reactions. Key findings from his group and collaborations have elucidated microbial pathways that modulate therapeutics studied in teams with researchers from Harvard Medical School, Massachusetts Institute of Technology, and the Broad Institute. His work demonstrated microbial biotransformation of orally administered compounds, building on conceptual frameworks from investigators at Rockefeller University and mechanistic insights used by groups at the Scripps Research Institute.

Notable discoveries include identification of microbial enzymes that alter chemotherapeutic and cardiometabolic drugs, mapping of diet-microbiome interactions that echo population studies from Johns Hopkins University and Columbia University, and characterization of interindividual variation driven by microbial gene content akin to approaches developed at Stanford University and MIT. These contributions have informed translational strategies investigated in clinical trials at centers like Dana-Farber Cancer Institute and Vanderbilt University Medical Center.

Awards and honors

Turnbaugh has received recognition from academic and philanthropic organizations involved in microbiome research and biomedical innovation. His awards include honors and fellowship support comparable to those granted by entities such as the National Institutes of Health, the Gordon and Betty Moore Foundation, and professional societies connected to the American Society for Microbiology and the American Association for the Advancement of Science. He has been invited to present findings at meetings organized by the Cold Spring Harbor Laboratory, the Gordon Research Conferences, and symposia hosted by the Keystone Symposia on Molecular and Cellular Biology.

Selected publications and media coverage

Representative publications from Turnbaugh's laboratory have appeared in journals and venues associated with institutions like Cell, Nature, Science Translational Medicine, and Proceedings of the National Academy of Sciences. His research has been covered by major outlets and institutional communications linked to The New York Times, The Washington Post, Nature News, and university press offices at University of California, Berkeley and University of California, San Francisco. Media pieces have highlighted implications for personalized medicine efforts at organizations such as Genentech, Novartis, and start-ups emerging from the Bioconductor and microbiome biotechnology ecosystems.

Category:American microbiologists Category:Microbiome researchers